Y043-6264 Screening compound: 2-{[3-(3,4-dimethoxyphenyl)-2-oxo-2H-chromen-7-yl]oxy}-N-{2-[(1S,9R)-6-oxo-7,11-diazatricyclo[7.3.1.0~2,7~]trideca-2,4-dien-11-yl]ethyl}acetamide

Y043-6264 Screening compound: 2-{[3-(3,4-dimethoxyphenyl)-2-oxo-2H-chromen-7-yl]oxy}-N-{2-[(1S,9R)-6-oxo-7,11-diazatricyclo[7.3.1.0~2,7~]trideca-2,4-dien-11-yl]ethyl}acetamide
Y043-6264 Screening compound: 2-{[3-(3,4-dimethoxyphenyl)-2-oxo-2H-chromen-7-yl]oxy}-N-{2-[(1S,9R)-6-oxo-7,11-diazatricyclo[7.3.1.0~2,7~]trideca-2,4-dien-11-yl]ethyl}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Y043-6264
2-{[3-(3,4-dimethoxyphenyl)-2-oxo-2H-chromen-7-yl]oxy}-N-{2-[(1S,9R)-6-oxo-7,11-diazatricyclo[7.3.1.0~2,7~]trideca-2,4-dien-11-yl]ethyl}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y043-6264

Molecular Formula

C32H33N3O7 (C32 H33 N3 O7)

Compound Name

2-{[3-(3,4-dimethoxyphenyl)-2-oxo-2H-chromen-7-yl]oxy}-N-{2-[(1S,9R)-6-oxo-7,11-diazatricyclo[7.3.1.0~2,7~]trideca-2,4-dien-11-yl]ethyl}acetamide

IUPAC name

2-{[3-(34-dimethoxyphenyl)-2-oxo-2H-chromen-7-yl]oxy}-N-{2-[(1S9R)-6-oxo-711-diazatricyclo[7.3.1.0^{27}]trideca-24-dien-11-yl]ethyl}acetamide

SMILES

COc(ccc(C1=Cc(ccc(OCC(NCCN(C[C@@H](C2)CN34)C[C@H]2C4=CC=CC3=O)=O)c2)c2OC1=O)c1)c1OC

InChI

InChI=1S/C32H33N3O7/c1-39-27-9-7-21(14-29(27)40-2)25-13-22-6-8-24(15-28(22)42-32(25)38)41-19-30(36)33-10-11-34-16-20-12-23(18-34)26-4-3-5-31(37)35(26)17-20/h3-9,13-15,20,23H,10-12,16-19H2,1-2H3,(H,33,36)/t20-,23-/m0/s1

InChI Key

JNPCJXJYOLIJMY-REWPJTCUSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

571.63

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

2.620

Distribution Coefficient, logD

2.171

Water Solubility, LogSw

-3.07

Polar Surface Area

87.371

Acid Dissociation Constant (pKa)

13.94

Base Dissociation Constant (pKb)

7.66

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

34.38

Y043-6264 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CORONAVIRUS Library (20774 compounds)

PLpro Library (6343 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system

References: we are preparing a list of scientific research reports with Y043-6264 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y043-6264?
Check Price and Availability of Y043-6264, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y043-6264 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y043-6264
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y043-6264
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y043-6264 available by request